EPI-WIN digest 17 - Treatment and medical support for patients with mpox, and their families

Overview

The global mpox outbreak, which began in 2022, has resulted in over 100,000 confirmed cases reported to the WHO. The rapid spread of the new Clade 1B strain, particularly in eastern DRC and neighbouring countries and its recent detection in Sweden and Thailand, underscores the growing threat. This escalating situation led to the declaration of a Public Health Emergency of International Concern on 14 August 2024.

WHO in partnership with international and regional organisations is leading the global response by providing strategic leadership, including through providing clinical expertise to improve supportive care both in hospitals and at home; developing and updating response guidance for the control of Mpox that includes infection prevention control measures, how to screen, triage and isolate patients and how to manage mild and complicated Mpox including skin lesions, complications with eyes, pain, good nutrition and hydration.  

For further information, please watch the EPI-WIN Webinar 'treatment and medical support for patients with mpox, and their families'.